Clinical trial
Functional Optical Coherence Tomography-Derived Biomarkers for Diabetic Retinopathy
NCT02330042 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional Optical Coherence Tomography-Derived Biomarkers for Diabetic Retinopathy
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 26, 2015
- Completion date
- December 31, 2026
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.